System and method for platelet removal during mononuclear cell collection

US10363355B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-10363355-B2
Application numberUS-201715693799-A
CountryUS
Kind codeB2
Filing dateSep 1, 2017
Priority dateSep 21, 2016
Publication dateJul 30, 2019
Grant dateJul 30, 2019

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

A method of collecting mononuclear cells, comprising separating whole blood into cellular components and platelets suspended in plasma, separating the platelets suspended in plasma into platelet concentrate and platelet-poor plasma, combining the cellular components with the platelet-poor plasma to form a first mixture, and separating the first mixture into mononuclear cells and at least one component.

First claim

Opening claim text (preview).

The invention claimed is: 1. A method of collecting mononuclear cells, comprising: separating whole blood into cellular components and platelet-rich plasma; separating the platelet-rich plasma into platelet concentrate and platelet-poor plasma; combining the cellular components with the platelet-poor plasma to form a first mixture; and separating the first mixture into mononuclear cells and at least one component. 2. The method of claim 1 , wherein the platelet-poor plasma contains fewer platelets than does the platelet-rich plasma. 3. The method of claim 1 , wherein the whole blood is separated into cellular components and platelet-rich plasma by a centrifugal separator. 4. The method of claim 3 , wherein the whole blood, the platelet-rich plasma and the first mixture are separated within a compartment of a separation chamber, with the cellular components and the platelet-rich plasma being directed to separate locations until separation of the whole blood is complete. 5. The method of claim 4 , wherein said separating whole blood into cellular components and platelet-rich plasma and said separating the first mixture into mononuclear cells and at least one component take place substantially in series. 6. The method of claim 3 , wherein the whole blood is separated within a first compartment of a separation chamber, with the platelet-rich plasma being directed to a second compartment of the separation chamber, and with the platelet-rich plasma being separated into platelet concentrate and platelet-poor plasma in the second compartment; and the first mixture is directed to and separated within the first or second compartment of the separation chamber. 7. The method of claim 6 , wherein said separating whole blood into cellular components and platelet-rich plasma and said separating the platelet-rich plasma into platelet concentrate and platelet-poor plasma take place substantially at the same time. 8. The method of claim 6 , further comprising stopping the directing of the platelet-rich plasma into the second compartment from the first compartment when an optical sensor disposed downstream of the first compartment detects that fluid leaving the first compartment has adequate clarity. 9. The method of claim 1 , wherein the whole blood is separated into cellular components and platelet-rich plasma by a spinning membrane separator. 10. The method of claim 1 , wherein said separating whole blood into cellular components and platelet-rich plasma and said separating the platelet-rich plasma into platelet concentrate and platelet-poor plasma take place substantially at the same time. 11. An automated system of collecting mononuclear cells, comprising: a separator including a controller; and a disposable fluid circuit configured to work in association with the separator, wherein the controller is configured to control the separator to separate whole blood in the disposable fluid circuit into cellular components and platelet-rich plasma, separate the platelet-rich plasma into platelet-concentrate and platelet-poor plasma, combine the cellular components with the platelet-poor plasma to form a first mixture, and separate the first mixture into mononuclear cells and at least one component. 12. The system of claim 11 , wherein the separator separating the whole blood into cellular components and platelet-rich plasma is a centrifugal separator. 13. The system of claim 11 , wherein the separator separating the whole blood into cellular components and platelet-rich plasma is a spinning membrane separator. 14. The system of claim 11 , wherein the whole blood is separated into cellular components and platelet-rich plasma, and the platelet-rich plasma is separated into platelet concentrate and platelet-poor plasma at substantially at the same time. 15. The system of claim 11 , wherein the platelet-rich plasma is separated into platelet concentrate and platelet-poor plasma, and the first mixture is separated into mononuclear cells and the at least one component substantially in series. 16. The system of claim 12 , wherein the disposable fluid circuit includes a separation chamber having a compartment, and the whole blood, platelet-rich plasma, and first mixture are separated in the compartment of the separation chamber. 17. The system of claim 12 , wherein the disposable fluid circuit includes a separation chamber having a first compartment and a second compartment, the whole blood is separated in the first compartment, and the platelet-rich plasma is separated in the second compartment. 18. The system of claim 17 , wherein the first mixture is separated in the first compartment. 19. The system of claim 17 , wherein the first mixture is separated in the second compartment. 20. The system of claim 17 , wherein the separator further includes an optical sensor configured to monitor a portion of the disposable fluid circuit downstream of the first compartment, and the controller is configured to stop directing platelet-rich plasma to the second compartment when the optical sensor detects that fluid leaving the first compartment has adequate clarity.

Assignees

Inventors

Classifications

  • White blood cells; Leucocytes · CPC title

  • Platelets; Thrombocytes · CPC title

  • Plasmapheresis; Leucopheresis; Lymphopheresis (A61M1/3472 takes precedence) · CPC title

  • Multiple bag systems for separating or storing blood components · CPC title

  • Removing constituents from donor blood and {storing or} returning remainder to body {, e.g. for transfusion} · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US10363355B2 cover?
A method of collecting mononuclear cells, comprising separating whole blood into cellular components and platelets suspended in plasma, separating the platelets suspended in plasma into platelet concentrate and platelet-poor plasma, combining the cellular components with the platelet-poor plasma to form a first mixture, and separating the first mixture into mononuclear cells and at least one co…
Who is the assignee on this patent?
Fenwal Inc
What technology area does this patent fall under?
Primary CPC classification A61M1/3693. Mapped technology areas include Human Necessities.
When was this patent published?
Publication date Tue Jul 30 2019 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).